Trials / Completed
CompletedNCT02788617
Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage
A Prospective, Non-interventional, Multicenter, Clinical Study to Evaluate the Efficacy of the Diafert G-CSF ELISA as an Adjunct to Morphological Assessment in Predicting Embryos' Potential to Develop to the Blastocyst Stage
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Forest Laboratories · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective study will evaluate the efficacy of Diafert as an adjunct to morphological assessment in predicting embryos' potential to develop to the blastocyst stage on Day 5.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Diafert | The Diafert output, the G-CSF concentration in FF, will be recorded but will not be used in patient management. |
Timeline
- Start date
- 2016-06-24
- Primary completion
- 2017-01-30
- Completion
- 2017-04-04
- First posted
- 2016-06-02
- Last updated
- 2017-07-31
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02788617. Inclusion in this directory is not an endorsement.